Skip to main content
VCbacked
Log inGet Started

Gestalt Diagnostics

Spokane, United States

Gestalt Diagnostics is an AI-powered digital pathology company that provides pathology solutions to diagnose diseases efficiently.

$7.5M raised
Apr 2025
Series A
BiotechnologyHealth CareLife ScienceMedical

Top Investors

TechVision FundCowles VenturesInland ImagingPuget Sound Venture ClubTV

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gestalt Diagnostics

How much funding has Gestalt Diagnostics raised?
Gestalt Diagnostics has raised $7.5M in total funding. The most recent round was Series A. The last funding was announced in April 2025.
Who are Gestalt Diagnostics's investors?
Gestalt Diagnostics's investors include TechVision Fund, Cowles Ventures, Inland Imaging, Puget Sound Venture Club, TV.
Where is Gestalt Diagnostics headquartered?
Gestalt Diagnostics is headquartered in Spokane, United States.
What does Gestalt Diagnostics do?
Gestalt Diagnostics is an AI-powered digital pathology company that provides pathology solutions to diagnose diseases efficiently.
What stage is Gestalt Diagnostics at?
Gestalt Diagnostics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Gestalt Diagnostics — Funding & Investors." VCBacked, April 28, 2025, https://www.vcbacked.co/company/gestalt-diagnostics. Accessed June 9, 2026.
APA
VCBacked. (2025). Gestalt Diagnostics — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/gestalt-diagnostics
Wikipedia (cite web)
{{cite web |title=Gestalt Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/gestalt-diagnostics |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong